Q4 2019 Holdings
Filed 2020-02-13 | 99 holdings | $617.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $115.2M | 1,000,000 | 18.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $106.1M | 640,000 | 17.2% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $95.4M | 450,000 | 15.5% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $89.0M | 2,628,130 | 14.4% |
| Avantor Inc(AVTR) | COM | 05352A100 | $86.2M | 4,750,000 | 14.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $56.2M | 350,000 | 9.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $28.7M | 600,000 | 4.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $13.9M | 100,000 | 2.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.0M | 200,000 | 1.1% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $6.6M | 500,000 | 1.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $4.5M | 150,000 | 0.7% |
| Alector Inc(ALEC) | COM | 014442107 | $3.9M | 225,000 | 0.6% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.7M | 425,000 | 0.4% |
| WW Intl Inc(WW6) | COM | 98262P101 | $566.2K | 14,818,300 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $250.0K | 60,240,864 | 0.0% |
| Morgan Stanley(MS)Call | COM NEW | 617446448 | $102.2K | 2,000,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $90.1K | 4,606,298 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $63.6K | 1,200,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $55.4K | 2,250,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $39.1K | 2,000,000 | 0.0% |
| Zillow Group Inc(Z) | CL C CAP STK | 98954M200 | $34.5K | 750,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $33.6K | 2,546,040 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $32.0K | 400,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $31.2K | 1,819,186 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $29.2K | 3,000,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $28.8K | 1,750,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $26.9K | 2,833,791 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $25.1K | 1,608,968 | 0.0% |
| Paypal Hldgs Inc(PYPL) | COM | 70450Y103 | $21.6K | 200,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $18.9K | 550,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $18.7K | 300,000 | 0.0% |
| Aravive Inc(VSAREUR) | COM | 03890D108 | $18.5K | 1,350,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $17.2K | 400,000 | 0.0% |
| Stoneco LTD(STNE) | COM CL A | G85158106 | $16.0K | 400,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $15.6K | 250,000 | 0.0% |
| Uber Technologies Inc(UBER) | COM | 90353T100 | $14.9K | 500,000 | 0.0% |
| American Airls Group Inc(AAL)Call | COM | 02376R102 | $14.3K | 500,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $13.8K | 500,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $13.6K | 360,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $13.5K | 350,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $12.9K | 1,300,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $12.6K | 850,000 | 0.0% |
| Y Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $12.5K | 400,000 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $12.3K | 1,004,987 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $11.4K | 450,200 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $11.0K | 500,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $10.8K | 150,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $10.8K | 500,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $10.4K | 1,000,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $10.2K | 50,000 | 0.0% |